Bridgefront Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-76,917
Closed -$1.84M – 584
2026
Q1
$1.84M Buy
+76,917
New +$1.88M 0.46% 50
2023
Q2
– Sell
-26,948
Closed -$253K – 520
2023
Q1
$253K Buy
+26,948
New +$318K 0.15% 259
2022
Q4
– Sell
-24,641
Closed -$306K – 399
2022
Q3
$306K Sell
24,641
-550
-2% -$9.61K 0.31% 128
2022
Q2
$494K Buy
+25,191
New +$596K 0.55% 33
2021
Q3
– Sell
-8,682
Closed -$301K – 439
2021
Q2
$301K Buy
+8,682
New +$286K 0.11% 338

Other funds holding ELAN

Bridgefront Capital's ELAN Position: Q2 2026 in Review

Bridgefront Capital sold out of Elanco Animal Health (ELAN) in Q2 2026, closing a stake of 76,917 shares — an estimated $1.84M sold.

Bridgefront Capital first reported a position in ELAN in Q2 2021 and held it in 5 quarters. The position peaked at $1.84M in Q1 2026. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Bridgefront Capital reported no remaining Elanco Animal Health position as of Q2 2026 after selling out during the quarter.
  • Bridgefront Capital sold 76,917 Elanco Animal Health shares in Q2 2026, an estimated $1.84M.
  • Bridgefront Capital first reported a position in Elanco Animal Health in Q2 2021 and held it in 5 quarters.
  • Bridgefront Capital's Elanco Animal Health position peaked at $1.84M in Q1 2026.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.